Sugi Predict

Sugi Predict / Compounds / SCHEMBL914447

SCHEMBL914447

SCHEMBL914447

OC[C@H]1O[C@@](COC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O

nearest known ligand 0.76

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.76
▸ CCNB1 P14635 1/20 0.76
▸ CA2 P00918 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ TYR P14679 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ LDHA P00338 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736074 1.00 CDK1 (0.76) CDK1CCNB1CA2CA9MEN1
SCHEMBL181304 1.00 CDK1 (0.76) CDK1CCNB1CA2CA9MEN1
SCHEMBL4762882 1.00 CDK1 (0.76) CDK1CCNB1CA2CA9MEN1
SCHEMBL4764191 1.00 CDK1 (0.76) CDK1CCNB1CA2CA9MEN1
SCHEMBL346869 1.00 CDK1 (0.76) CDK1CCNB1CA2CA9MEN1
SCHEMBL29524904 0.96 CDK1 (0.83) CDK1CCNB1CA2CA9MEN1
SCHEMBL875991 0.90 CDK1 (0.66) CDK1CCNB1CA2CA9MEN1
SCHEMBL2808642 0.89 CDK1 (0.64) CDK1CCNB1CA2CA9MEN1
SCHEMBL5081419 0.88 CDK1 (0.61) CDK1CCNB1CA2CA9MEN1
Raffinose SCHEMBL23549944 0.88 CDK1 (0.97) CDK1CCNB1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112961888-B Application of recombinase in synthesis of glucan containing alpha- (1, 2) glycosidic bond 东北师范大学 2023-05-05 — — CN claimed
US-8465761-B2 Piglet feed rations having low levels of fermentable carbohydrates NOVUS INTERNATIONAL, INC. (US) 2013-06-18 — — US claimed
US-7727962-B2 Powder comprising new compositions of oligosaccharides and methods for their preparation BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-06-01 — — US claimed
US-7723306-B2 Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-05-25 — — US claimed
US-7611709-B2 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives BOEHRINGER INGELHEIM PHARMA GMBH AND CO. KG (DE) 2009-11-03 — — US claimed
US-20090169501-A1 MASCARA CONTAINING A SUGAR SILICONE SURFACTANT L'OREAL S.A (FR) 2009-07-02 — — US claimed
CN-101316598-A Butyrate esters of carbohydrates and carbohydrate polyols SUEDZUCKER AG (DE) 2008-12-03 — — CN claimed
US-20080213341-A1 Butyric Acid Esters of Carbohydrates and Carbohydrate Polyols SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT (DE) 2008-09-04 — — US claimed
WO-2008088196-A1 POWDER COMPOSITION OF HYGROSCOPIC SUBSTANCES AND MANUFACTURING METHO THEREOF SAMYANG GENEX CORPORATION (KR) 2008-07-24 — — WO claimed
EP-1789019-B1 POWDERS CONTAINING NOVEL OLIGOSACCHARIDE MIXTURES AND METHODS FOR PRODUCING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2008-01-16 — — EP claimed
US-20050250705-A1 Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation BOEHRINGER INGELHEIM PHARMA GMBH CO. KG (DE) 2005-11-10 — — US claimed
US-20050250704-A1 Powder comprising new compositions of oligosaccharides and methods for their preparation BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-11-10 — — US claimed
US-20050238777-A1 Condensed palatinose and method for producing the same SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT (DE) 2005-10-27 — — US claimed
US-20050222406-A1 Condensed palatinose in hydrogenated form SUDZUCKER AKTIENGESELLSCHAFT (DE) 2005-10-06 — — US claimed
CN-1668755-A Galactosyl isomalt, method for production and use thereof SUEDZUCKER AG (DE) 2005-09-14 — — CN claimed
CN-1659176-A Condensed palatinose and method for producing the same SUEDZUCKER AG (DE) 2005-08-24 — — CN claimed
US-6777040-B2 SYNERGISTIC MIXTURE OF OLIGOSACCHARIDE AND METAL COMPOUND; SHARP IMAGE TOMOEGAWA PAPER CO., LTD (JP) 2004-08-17 — — US claimed
US-20030049481-A1 Recording sheet for ink jet printer TOMOEGAWA PAPER CO., LTD. 2003-03-13 — — US claimed
EP-1288007-A2 Recording sheet for ink jet printer Tomoegawa Paper Co. Ltd. (JP) 2003-03-05 — — EP claimed
EP-1111065-A2 Production of saccharide carboxylic acids TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-27 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250704-A1 Powder comprising new compositions of oligosaccharides and methods for their preparation DDOST, MGAT3, MGAM CDK1 2962/4885CCNB1 2987/4885CA2 1344/4885
US-20050250705-A1 Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation MGAT3, MGAM, FUT6 CDK1 3322/4885CCNB1 3635/4885CA2 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.